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Abstract
Background: Nasopharyngeal carcinoma (NPC) is an epithelial malignancy highly prevalent in southern China,
and incidence rates among Han Chinese people vary according to geographic region. Recently, three independent
genome-wide association studies (GWASs) confirmed that HLA-A is the main risk gene for NPC. However, the results
of studies conducted in regions with dissimilar incidence rates contradicted the claims that HLA-A is the sole risk
gene and that the association of rs29232 is independent of the HLA-A effect in the chromosome 6p21.3 region.
Methods: We performed a meta-analysis, selecting five single-nucleotide polymorphisms (SNPs) in chromosome
6p21.3 mapped in three published GWASs and four case–control studies. The studies involved 8994 patients with
NPC and 11,157 healthy controls, all of whom were Han Chinese.
Results: The rs2517713 SNP located downstream of HLA-A was significantly associated with NPC (P = 1.08 × 10−91,
odds ratio [OR] = 0.58, 95 % confidence interval [CI] = 0.55–0.61). The rs29232 SNP exhibited a moderate level of
heterogeneity (I2 = 47 %) that disappeared (I2 = 0 %) after stratification by moderate- and high-incidence NPC regions.
Conclusions: Our results suggested that the HLA-A gene is strongly associated with NPC risk. In addition, the
heterogeneity revealed by the meta-analysis of rs29232 might be associated with regional differences in NPC incidence
among Han Chinese people. The higher OR of rs29232 and the fact that rs29232 was independent of the HLA-A effect
in the moderate-incidence population suggested that rs29232 might have greater relevance to NPC incidence in a
moderate-incidence population than in a high-incidence population.
Background
Nasopharyngeal carcinoma (NPC), a malignancy that
forms in the epithelium of the nasopharynx, has a
distinct geographic distribution and is highly prevalent
in southern China, Southeast Asia, and North Africa.
Although all Han Chinese populations exhibit an in-
creased risk of NPC, the incidence rate varies by region.
For example, male populations in Guangdong and
Guangxi in southern China have consistently exhibited a
higher incidence rate (20.6–39.94/100 000 person-years)
compared with those in moderate-incidence regions,
such as Taiwan (8.6/100 000 person-years), and those in
most of the Western world (less than 1/100 000 person-
years) [1–5]. The etiology of NPC is multifactorial,
involving genetic components, Epstein–Barr virus infec-
tion, and other types of environmental exposure [1]. The
variations in NPC incidence might be due to differences
in environmental exposure among geographic regions;
however, the genetic components underlying the differ-
ences in incidence in Han Chinese populations remain
underexplored.
The genetic association of human leukocyte antigen
(HLA) class I genes, particularly HLA-A, with NPC was
established in 1974 [6] and has been confirmed in more
than 100 association studies adopting traditional HLA
genotyping techniques. Studies have consistently identified
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an association between NPC and HLA-A*1101, HLA-
A*0207, and HLA-B*5801 [7–9]. The distribution of these
three alleles in the human genome appears to be consist-
ent with the geographical distribution of NPC incidence in
southeastern China; the allele frequency is particularly
high in regions with high NPC incidence rates [10–12].
However, no difference in HLA allele frequency has been
observed in the results of NPC association studies con-
ducted in regions with various incidence rates [13–15],
suggesting that the HLA genes might not directly lead to
differences in NPC incidence.
Three independent genome-wide association studies
(GWASs) [16–18] have identified multiple significant
association signals in chromosome 6p21.3 near the HLA-
A gene, which exhibited extremely strong linkage disequi-
librium (LD) (Fig. 1). These observations raised the
question as to whether these associated single-nucleotide
polymorphisms (SNPs) represent an independent effect or
are only proxies of the HLA-A gene. Studies conducted in
medium- and high-incidence regions (Taiwan [16, 19],
and Guangdong and Guangxi [17, 18], respectively) have
yielded contradictory conclusions.
To evaluate the effect of HLA-A and its neighboring
gene on NPC susceptibility, we conducted a meta-
analysis on the association between the five most fre-
quently studied chromosome 6p21.3 SNPs (rs9260734,
rs2517713, rs3129055, rs29232, and rs29230) and NPC
susceptibility. Thus far, no meta-analysis has been con-
ducted to explore the overall NPC risk and the genetic
heterogeneity associated with chromosome 6p21 SNPs.
In the current study, we postulated that moderate
heterogeneity in rs29232 might contribute to the re-
gional variation in NPC incidence rates.
Methods
Identification and eligibility of relevant studies
We reviewed the literature on PubMed for all relevant
reports (the most recent search update was December
10, 2014), using the search terms “NPC,” “association,”
and “HLA,” and limiting the results to English-language
papers. In this meta-analysis, studies had to fulfill the
following criteria: 1) evaluate the correlation between
SNPs mapped by GWASs in the HLA-A region and
NPC in Han Chinese populations, 2) use a case–control
design, and 3) report the genotype frequency for both
cases and controls and/or odds ratios (ORs).
Description of studies
The meta-analysis was based on summary data reported
by three previous GWASs on NPC [16–18] and four
follow-up case–control studies [19–22] focusing on the
HLA class I region. We extracted data according to the
aforementioned inclusion criteria. The following data
was collected from each study: 1) first author’s name, 2)
year of publication, 3) sample collection area, 4) geno-
typing platform, 5) SNPs assessed, 6) number of cases
and controls, 7) sex ratio, and 8) age range (Table 1).
Twelve SNPs discovered by Tse et al. [16] were used as
major targets for analysis; the citation of these SNPs was
standardized using rs numbers, as suggested by Tse et al.
For rs2517713, two SNPs (rs2860580 and rs9260475)
acted as surrogates according to the strong LD
Fig. 1 Chromosome 6p21.3 polymorphisms discovered in three NPC GWASs. Top: The triangles indicate the P values reported by the GWASs
on a negative logarithmic scale according to the chromosome locations of the SNPs. Red: Tse [16]; Green: Bei [17]; Blue: Tang [18]. The solid
triangles indicate the SNPs used in the meta-analysis. The hollow triangles indicate the other SNPs listed in the GWASs. Bottom: Detailed LD
structure depicted in HaploView by using control samples from the NPC GWAS in Taiwan [16]. The increasing intensities of red represent lower
D’ values
Su et al. BMC Cancer  (2015) 15:598 Page 2 of 8
Table 1 Characteristics of the studies included in the meta-analysis
Stage I Stage II
Sample Genotyping Sample Gender (%)a Ageb Genotyping Sample Gender (%)a Ageb
Study Population Method SNPs Case Control Case Control Case Control Method Case Control Case Control Case Control
Tse (2009) Taiwan Illumina Hap550 480,365 277 285 76 67 49 (12) 50 (14) TaqMan 635 1,640 73 73 50 (13) 59 (14)
Bei (2010) Guangdongc Illumina Hap610 464,328 1,583 1,894 73 69 46 (11) 47 (11) TaqMan 3,507 3,063 74 67 46 (12) 44 (12)
Tang (2012) Guangxi and Guangdong Affymatrix 6.0 591,458 567 476 - - - - TaqMan 923 1,105 - - - -
Li (2011) Guangdong TaqMan 233 360 360 72 34 46 (11) 41 (9)
Zhao (2012) Guangdong SNPstream 100 206 180 71 67 - - Sequenome 535 525 73 76 - -
Hsu (2012) Taiwan TaqMan 12 337 286 70 70 46 46
Gao (2014) Guangdong and Guangxi TaqMan 16 350 619 67 43 45 (11) 46 (10) TaqMan 816 1721 73 61 45 (11) 46 (12)











relationship between the target and surrogate SNPs in
the HapMap Han Chinese in Beijing (CHB) population
(rs2860580–rs2517713: D’ = 1, r2 = 0.90; rs9260475–
rs2517713: D’ = 1, r2 = 0.91). When available, the fol-
lowing information was obtained from the studies and
included in the meta-analysis: 1) minor allele frequency
(MAF) in the case and control samples, 2) P values for
the original association, and 3) ORs and 95 % confi-
dence intervals (CIs). When the target SNPs were geno-
typed in both the discovery and validation groups, the
combined genotyping data was used.
Assessment of publication bias
Typical publication bias is a result of small sample sizes.
Although the studies included in the meta-analysis had
an adequate number of cases, the sample sizes were
small compared with those of GWASs on other types of
cancer. Furthermore, a low level of population admix-
ture in a large study can cause publication bias. There-
fore, potential publication bias was assessed using funnel
and P–M plots [23, 24]. Funnel plotting and Egger’s
linear regression test were performed using the Metafor
package [23] in R [25], Version 3.0.2. When publication
bias occurred, the funnel plot was noticeably asymmet-
ric. Egger’s linear regression test was used to test the
funnel-plot symmetry. The M values of P–M plots rep-
resented the posterior probability that an effect existed
in each study. A low M value (<0.1) suggested that the
study had no effect, and therefore, such studies were
excluded from further analysis [24].
Meta-analysis
All meta-analysis results presented in this report were
calculated using the Metasoft software package, Version
2.0.1 [26]. The P–M plot, forest plot, and funnel plot
were plotted using Metafor [27]. To evaluate the associ-
ation between 6p21.3 SNPs and the risk of NPC, we
calculated the pooled ORs and associated 95 % CIs.
Standard meta-analysis involving the fixed effects model
and conventional random effects model was conducted
using the standard error and effect size reported in each
study [24, 27]. If the target SNPs were genotyped in both
discovery and validation stages (Table 1), the combined
data was used, otherwise only stage I data was used for
meta-analysis. The fixed effects model made a condi-
tional inference on the heterogeneity among the true
effects, whereas the conventional random effects model
treated the heterogeneity as purely random. Sensitivity
analysis was conducted to assess the potential influences
of any single study on the pooled ORs. In each meta-
analysis, included studies were individually removed to
ensure that no study significantly altered the pooled ORs
and associated P values. Power analysis was conducted
using the Power and Sample Size Calculation software
Version 3.1.2 [28, 29].
Test of heterogeneity
The heterogeneity effect was quantified using the I2 test
[30]. The I2 values ranged from 0 to 100 %, and values
of 25, 50, and 75 % were considered to represent low,
moderate, and high levels of heterogeneity, respectively.
Heterogeneity was estimated using Cochran’s Q statistic,




The primary search yielded 59 articles, of which seven were
identified as potentially relevant, following a review of the
title and abstract. In total, seven studies were included in
the meta-analysis after a full-text review (Additional file 1:
Figure S1). The overall study population in the current
meta-analysis comprised 20,151 subjects, of which 8994
were patients with NPC and 11,157 were controls. We
analyzed seven studies that examined Han Chinese sub-
jects from Taiwan [16, 19], Guangdong [17, 18, 20–22],
and Guangxi [18, 22] (Table 1) and assessed five chromo-
some 6p21.3 SNPs: (rs9260734 [HCG6], rs2517713 [HLA-A],
rs3129055 [HLA-F], rs29232 [GABBR1], and rs29230
[GABBR1]). Two surrogate SNPs, rs2860580 [17] and
rs9260475 [21], represented rs2517713 because the LD
(D’= 1, r2 > 0.9) between the target and surrogate SNPs in
the HapMap CHB population was extremely high [32].
Publication bias and synthesis of results
We used P–M and funnel plots to assess the publication
bias of the included studies, detecting no evidence of poten-
tial publication bias in our target SNPs (Additional file 1:
Figure S2). As expected, rs2517713 of the HLA-A gene was
the most significantly associated with NPC (OR= 0.58,
95 % CI = 0.55–0.61, P = 1.08 × 10−91) (Table 2). Analysis of
three of the five SNPs did not reveal heterogeneity (I2 = 0).
Although we used surrogate SNPs (rs2860580 and
rs9260475) in the meta-analysis of rs2517713, we did not
observe publication bias (Additional file 1: Figure S2b) or
heterogeneity (I2 = 0, Table 2), suggesting that SNPs with
high LD (D’ = 1, r2 > 0.9) could be treated as the same SNP
in the meta-analysis. We observed a moderate level of het-
erogeneity in rs3129055 (I2 = 58 %, P = 0.0361) and rs29232
(I2 = 47 %, P = 0.1091); however, the heterogeneity for
rs29232 was not statistically significant (P > 0.1). Because
Cochran’s Q statistic is severely underpowered in analyses
with only four to five studies, heterogeneity might still exist
despite a lack of nominal statistical significance [33]. Two
SNPs that exhibited heterogeneity (rs3129055 and rs29232)
were the same SNPs independent from the HLA-A
effect [16]. The random effect of rs29232 exhibited a
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Table 2 Meta-analysis of the associations between chromosome 6p21 SNPs and NPC susceptibility
Sample MAF Heterogeneity
Gene SNP Study Case Control Case Control P OR 95 % CI I2 % P
HCG9 rs9260734 Tse (2009) 912 1,925 0.22 0.34 6.77E-18 0.54 0.47–0.62
Bei (2010) 1,583 1,894 0.22 0.33 9.80E-22 0.56 0.49–0.67
Tang (2012) 923 1,105 - - 2.63E-11 0.59 0.50–0.69
Li (2011) 360 360 0.25 0.32 9.70E-03 0.74 0.53–1.01
Zhao (2012) 535 525 - 0.32 3.30E-07 0.60 0.49–0.73
Hsu (2012) 336 288 0.24 0.35 1.88E-03 0.57 0.40–0.81
Guo (2014) 1166 2340 - - 5.96E-17 0.60 0.53–0.68
Fixed effect 9.68E-57 0.59 0.55–0.63 0 0.7774
Random effect 9.68E-57 0.59 0.55–0.63
HLA-A rs2517713 Tse (2009) 912 1,925 0.24 0.38 3.90E-20 0.53 0.47–0.61
rs2860580a Bei (2010) 5,090 4,957 - - 3.65E-65 0.58 0.54–0.62
Tang (2012) 923 1,105 - - 1.92E-11 0.60 0.52–0.70
Li (2011) 360 360 0.28 0.36 5.30E-04 0.67 0.48–0.91
rs9260475a Zhao (2012) 206 180 - 0.38 1.00E-04 0.49 0.34–0.70
Hsu (2012) 337 286 0.26 0.38 1.90E-03 0.58 0.41–0.82
Guo (2014) 1166 2340 - - 2.44E-16 0.62 0.55–0.70
Fixed effect 1.08E-91 0.58 0.55–0.61 0 0.5265
Random effect 1.08E-91 0.58 0.55–0.61
HLA-F rs3129055 Tse (2009) 912 1,925 0.41 0.31 7.36E-11 1.51 1.34–1.71
Bei (2010) 1,583 1,894 0.37 0.30 3.00E-07 1.31 1.19–1.58
Tang (2012) 923 1,105 - - 3.43E-02 1.17 1.01–1.34
Li (2011) 360 360 0.36 0.34 3.69E-01 1.11 0.81–1.50
Hsu (2012) 344 294 0.38 0.30 4.44E-02 1.42 1.02–1.98
Guo (2014) 1166 2340 - - 2.00E-02 1.14 1.02–1.28
Fixed effect 6.44E-12 1.26 1.18–1.34 58 0.0361
Random effect 1.43E-05 1.28 1.14–1.42
GABBR1 rs29232 Tse (2009) 912 1,925 0.59 0.46 8.97E-17 1.67 1.48–1.88
Bei (2010) 1,583 1,894 0.53 0.43 3.90E-18 1.56 1.43–1.75
Tang (2012) 923 1,105 - - 4.35E-06 1.36 1.20–1.56
Hsu (2012) 342 290 0.53 0.41 2.41E-03 1.63 1.19–2.24
Guo (2014) 1166 2340 - - 1.85E-08 1.35 1.21–1.49
Fixed effect 1.46E-30 1.45 1.36–1.54 47 0.1092
Random effect 1.90E-16 1.47 1.34–1.61
GABBR1 rs29230 Tse (2009) 912 1,925 0.18 0.26 4.77E-09 0.64 0.56–0.75
Bei (2010) 1,583 1,894 0.19 0.27 1.30E-12 0.64 0.54–0.75
Tang (2012) 923 1,105 - - 9.48E-09 0.61 0.52–0.72
Li (2011) 360 360 0.18 0.27 1.43E-04 0.61 0.42–0.86
Hsu (2012) 341 290 0.17 0.25 2.34E-02 0.63 0.43–0.93
Guo (2014) 1166 2340 - - 1.36E-13 0.62 0.57–0.67
Fixed effect 5.78E-34 0.62 0.57–0.67 0 0.9988
Random effect 5.78E-34 0.62 0.57–0.67
aSNPs used as surrogate for rs2517713. The r2 between rs2860580 and rs2517713 was 0.91; r2 between rs2860580 and rs9260475 was 0.90
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highly significant P value of 1.90 × 10−16 (OR = 1.47,
95 % CI = 1.34–1.61); however, the random effect of
rs3129055 (P = 1.43 × 10−5, OR = 1.28, 95 % CI = 1.14–1.42)
did not exhibit genome-wide significance (<10−7).
Sensitivity analysis
To investigate the potential influence of a single study
on the overall meta-analysis estimation, we omitted one
study at a time. Similar results were obtained for the
three SNPs that did not exhibit heterogeneity
(rs9260734, rs2517713, and rs29230) regardless of any
study being omitted (Additional file 1: Table S1), indi-
cating that our results were supported by reliable data.
The ORs and I2 of the two SNPs exhibiting heterogen-
eity (rs3129055 and rs29232) calculated using the sensi-
tivity test differed. Power analysis of each target SNP in
the total sample size involved the following assump-
tions: two-tailed α = 0.05 and the frequency of minor
alleles in control samples. According to the ORs ob-
tained through meta-analysis, the present sample size
showed a power of 1.00 for detecting a significant
association.
Subgroup analysis
We stratified the studied population on the basis of
region, namely the moderate-incidence region (Taiwan)
[16, 19] and high-incidence regions (Guangdong and
Guangxi) [17, 18, 22] (Table 3). The heterogeneity de-
creased markedly from 47 to 0 % in both the moderate-
and high-incidence regions, suggesting that the hetero-
geneity of rs29232 was attributable to the geographical
difference in NPC incidence.
Discussion and conclusions
In the present meta-analysis, four of the five chromo-
some 6p21.3 polymorphisms exhibited strong and con-
sistent positive associations with NPC. The three SNPs
(rs2517713, rs9260734, and rs29230) yielded highly con-
sistent results with no heterogeneity, despite differences
in the genotyping platform (Table 1) and the use of
surrogate SNPs for rs2517713 (Table 2). The strongest
association was discovered in rs2517713 near the HLA-A
gene (P = 1.08 × 10−91, OR = 0.58, 95 % CI = 0.55–0.61),
further confirming the critical role of the HLA-A gene
in the susceptibility of NPC.
NPC has a distinct ethnic and geographic distribution.
The allele frequencies of NPC-associated alleles (HLA-
A*1101, HLA-A*0207, and HLA-B*5801) in the human
genome are consistent with the geographical distribution
of NPC incidence in southeastern Asia [10–12], suggest-
ing that the genetic differences among populations
might play a crucial role in NPC incidence. However, in
the NPC association studies, the frequency of HLA al-
leles did not differ noticeably in populations with
dissimilar incidence rates, suggesting that HLA genes
might not directly cause this difference. In the current
meta-analysis, we did not observe heterogeneity in the
HLA-A SNPs, which supports our hypothesis. By
contrast, our analysis indicated that rs29232 exhibited
distinct features in Han Chinese populations in regions
with different incidence rates. First, the heterogeneity of
rs29232 was markedly reduced when we stratified the
meta-analysis according to the incidence region. Second, in
the subgroup analysis, the OR of rs29232 was higher in
moderate-incidence regions than in the high-incidence
regions. Finally, in previous NPC association studies,
rs29232 was independent of the HLA-A effect in moderate-
incidence regions, but not in high-incidence regions. These
results suggest that rs29232 might contribute to the differ-
ence in NPC incidence in Han Chinese populations.
Studies conducted in regions with different incidence
rates have yielded inconsistent results regarding rs29232.
A GWAS conducted in Taiwan, a moderate-NPC-
incidence region, using multiple logistic regression ana-
lysis and stepwise logistic regression concluded that
rs29232 was significantly associated with NPC, even
after the removal of the HLA-A SNP (rs2517713) and
sequence-based HLA-A alleles (HLA-A*0207/0215 N
and HLA-A*110101/0121 N) [16]. Another independent
post-GWAS case–control study conducted in Taiwan
yielded similar results, indicating that HLA-A and rs29232
are likely to be independent risk factors for NPC, and that
NPC risk is highest among people carrying homozygous
HLA-A*0207 and rs29232 risk alleles [19]. By contrast, a
GWAS conducted in Guangdong, a high-NPC-incidence
region, revealed that the strength of the association with
rs29232 greatly diminished after the researchers controlled
for the effect of rs2860580 (HLA-A), whereas the strength
of the association with rs2860580 (HLA-A) decreased after
they adjusted for rs29232. Collectively, these results
Table 3 Meta-analysis of rs29232 in studies with samples from various incidence regions
Sample Fixed effect Random effect Heterogeneity
Population Case Control P OR 95 % CI P OR 95 % CI I2 % P
All 4,926 7,554 1.46E-30 1.45 1.36–1.54 1.90E-16 1.51 1.34–1.61 47 0.1092
Moderate incidence region Taiwan 1,254 2,215 3.43E-13 1.70 1.47–1.95 3.43E-13 1.70 1.47–1.95 0 0.7998
High incidence region Guangdong and Guangxia 3,672 5,339 2.92E-20 1.40 1.30–1.49 2.92E-13 1.40 1.30–1.49 0 0.4627
aMost of the samples were from high incidence region (Guangdong and Guangxi) except 922 controls were Han Chinese from Singapore
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suggest that the associations with rs29232 and rs2860580
(HLA-A) were correlated rather than probabilistically
independent [17]. In an NPC GWAS conducted in
Guangdong and Guangxi, a similar multivariate logistic
regression analysis indicated that rs29232- and GABBR1-
related SNPs were nonsignificant after adjustment for
HLA-A-related SNPs and alleles. The authors of the study
stated that all the other significant associations identified
were only proxies for HLA-A*1101 because of the strong
LD within the region [18]. To summarize, study findings
from moderate-incidence regions support the independent
role of rs29232, whereas those from high-incidence regions
indicate that only one true association signal (HLA-A)
exists within this chromosome region.
In the current study, no heterogeneity was observed
among studies except in rs3129055 (I2 = 58 %, P =
0.0361, HLA-F) and rs29232 (I2 = 47 %, P = 0.1092,
GABBR1). However, the heterogeneity in rs29232 was
not statistically significant (P > 0.1). Because tests of
heterogeneity are severely underpowered in analyses of
only a few studies [33], heterogeneity might still exist
despite a lack of statistical significance. Since the meta-
analysis result for rs3129055 did not achieve genome-
wide significance (<10−7), we excluded it from further
analysis. The moderate level of heterogeneity (I2 = 47)
of rs29232 markedly decreased (I2 = 0) when we
stratified the study population according to geographic
region (Table 3), suggesting that regional differences in
NPC incidence caused the heterogeneity. Furthermore,
the ORs were higher in the moderate-incidence regions
(OR = 1.70, 95 % CI = 1.47–1.95) than in the high-
incidence regions (OR = 1.40, 95 % CI = 1.30–1.49).
Since rs29232 was a significant association signal inde-
pendent of the effect of the HLA-A gene in the
moderate-incidence regions, we suspected that rs29232
caused the regional difference in NPC incidence among
Han Chinese people. Compared with high-incidence
populations, moderate-incidence populations might be
more strongly affected by rs29232.
Although the current evidence on the role of rs29232
and the GABBR1 gene seems self-contradictory, previous
studies have provided consistent findings regarding the
role of GABBR1 in NPC. GABBR1 encodes the protein
gamma-aminobutyric acid B receptor 1 (GABBR1), a G
protein-coupled receptor that forms a heterodimer with
GABAB receptor 2, thereby triggering downstream
signaling events involved in the proliferation, differenti-
ation, and migration of cancer cells. One study reported
that the intensity of the GABBR1 signal in tumor cells
was significantly higher than that detected in adjacent
normal epithelial cells (P < 0.001) in the immuno-
histochemical staining of NPC tissues [16].
The rs29232 SNP exhibited a lower LD (r2 < 0.6) than
did all other SNPs in the HapMap CHB data set in the
MHC region. This finding suggests that the role of
rs29232 might not directly relate to the downstream
GABBR1 gene or other neighboring genes, but rather
affect genes located in other regions or chromosomes
through long-range cis-acting or trans-acting. Neverthe-
less a recent genome-wide SNP–SNP interaction analysis
detected no significant interaction between rs29232 and
other SNPs [34]. Further investigation of the role of
rs29232 and its relationship with the incidence and eti-
ology of NPC is vital. In explorations of the genetic fac-
tors underlying disease susceptibility, epidemiological
factors, such as disease incidence rates, are rarely con-
sidered. In the current study, an association analysis of
rs29232 in regions with high or moderate incidence rates
was performed. Future studies conducted in low-
incidence regions such as northern China may clarify
the relationship between genetic factors and geographic
incidence rates. In addition, using imputation or next-
generation sequencing to explore the detailed genotypes
near rs29232 can further reveal the genetic causes
underlying the variation in regional NPC incidence rates.
The current study suggested that genetic effects might
be involved in epidemiological factors such as regional
disease incidences. However, epidemiological factors
have rarely been considered in large cross-region associ-
ation studies. Thus, we suggest that future large cross-
region meta-analyses include geographic incidence rates
as potential confounding factors.
In this meta-analysis, the results indicated a strong effect
of HLA-A on NPC susceptibility and a potential role of
rs29232 in the regional differences in NPC incidence
among Han Chinese people. However, this study had
several limitations. First, although the conclusion was based
on several previous studies, the heterogeneity for rs29232
observed in this study was nonsignificant. Second, although
the number of subjects in the studies included in the ana-
lysis was high, the number of studies included was relatively
low. Finally, meta-analyses constitute retrospective research
and, thus, are subject to methodological limitations. To
minimize potential bias, we used standard methods for
study selection, data extraction, and data analysis. Nonethe-
less, the results presented here should be interpreted with
caution until additional studies on rs29232 that control for
incidence rates according to region are conducted.
Additional file
Additional file 1: Supplementary Table S1. Sensitivity analysis of
meta-analysis. Supplementary Figure S1. PRISMA Flow chart of literature
review and study selection. Supplementary Figure S2. Forest plots,
funnel plots and P-M plots for NPC association. (PDF 1068 kb)
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